You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 137 No. 3, March 1977 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ARTICLES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (51)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Doxorubicin Hydrochloride-Associated Renal Failure

James F. Burke, Jr, MD; J. Frederick Laucius, MD; Harvey S. Brodovsky, MD; Raymond Z. Soriano, MD

Arch Intern Med. 1977;137(3):385-388.


Abstract



Doxorubicin hydrochloride (Adriamycin) therapy was associated with renal failure in a 78-year-old man. The pathophysiologic findings in this patient were similar to those seen following administration of structural analogues of doxorubicin. Daunorubicin hydrochloride, particularly, is known to cause renal failure in experimental animals. Renal function should be monitored in patients receiving doxorubicin.

(Arch Intern Med 137:385-388, 1977)



Author Affiliations



From the Departments of Medicine and Pathology, Jefferson Medical College, Philadelphia.


Footnotes



Accepted for publication June 23, 1976.

Reprint requests to Jefferson Medical College, Nephrology Division, 1025 Walnut St, Philadelphia, PA 19107 (Dr Burke).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Endothelial progenitors encapsulated in bioartificial niches are insulated from systemic cytotoxicity and are angiogenesis competent
Ratliff et al.
Am. J. Physiol. Renal Physiol. 2010;299:F178-F186.
ABSTRACT | FULL TEXT  

An Ancestral Haplotype Defines Susceptibility to Doxorubicin Nephropathy in the Laboratory Mouse
Zheng et al.
J. Am. Soc. Nephrol. 2006;17:1796-1800.
ABSTRACT | FULL TEXT  

Handling of Doxorubicin by the LLC-PK1 Kidney Epithelial Cell Line
Decorti et al.
J. Pharmacol. Exp. Ther. 1998;286:525-530.
ABSTRACT | FULL TEXT  

Enhanced Hexachloro-1:3-butadiene Nephrotoxicity in Rats with a Preexisting Adriamycin-Induced Nephrotic Syndrome
Kirby and Bach
Toxicol Pathol 1995;23:303-312.
ABSTRACT  

Drug Therapy in Renal Failure: Dosing Guidelines for Adults: Part II: Sedatives, Hypnotics, and Tranquilizers; Cardiovascular, Antihypertensive, and Diuretic Agents; Miscellaneous Agents
BENNETT et al.
ANN INTERN MED 1980;93:286-325.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1977 American Medical Association. All Rights Reserved.